Comparison

Toceranib European Partner

Item no. TMO-T13178-50mg
Manufacturer TargetMol
CASRN 356068-94-5
Amount 50mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 356068-94-5, PHA 291639E , SU11654
Available
Short Description
Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.
Shipping
cool pack
Storage
-20°
Target names or alias
PHA 291639E , SU11654
Molecular Weight
396, 46
Pathway
Tyrosine Kinase/Adaptors|||Angiogenesis
Target
VEGFR|||c-Kit|||PDGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?